martes, 28 de enero de 2020

Insulin is becoming Democrats’ signature drug pricing issue

D.C. Diagnosis
Nicholas Florko

Insulin is becoming Democrats’ signature drug pricing issue 

3c3c03eb-ead2-4257-b1a7-8430ed411081.png
JANELLE LUTGEN OUTSIDE OF SEN. BERNIE SANDERS’ CAMPAIGN HEADQUARTERS IN CEDAR RAPIDS, IOWA. (REBECCA F. MILLER FOR STAT)
As my colleague Lev Facher puts it in a new story out today for STAT: “Presidential candidates can’t stop talking about insulin.” Lev explains that unlike most health care issues, insulin pricing is easy to bring up in a stump speech: It’s the story of repeated price hikes for a nearly 100-year-old drug that has had life-and-death consequences for people around the country.

Lev spent the weekend traversing Iowa with Janelle Lutgen, a mother who turned into an activist after her son Jesse died from insulin rationing. For the past few months, she has been leaving presidential candidates with this message: To people with diabetes, insulin is worth its weight in gold — but that’s not what it should cost. She leaves them with little gold insulin vials to drive the point home.

Read Lev’s story here

No hay comentarios: